caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1851567879

Alan HoMD, PHD

PRACTICEMSKCCSee all providers at this practice →
Medical OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Alan Ho's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Hilda Stambuk
Diagnostic Radiology · New York, NY
1457
Robert Young
Diagnostic Radiology · New York, NY
1337
BAXI, SHRUJAL1299
Jamie Tisnado
Diagnostic Radiology · New York, NY
1143
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
137
Unique beneficiaries
—
Total services
327
Distinct HCPCS
4
Medicare payment
$40K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — below median (cohort median 458).
PRESCRIBING · PART D · 2024
Total Rx claims
142
Beneficiaries
—
Total drug cost
$549K
Distinct drugs
8
Brand share
33.1%
Top prescribed drugs
Levothyroxine Sodium28 claims
Dabrafenib Mesylate22 claims
Gabapentin16 claims
Pazopanib Hcl14 claims
Zolpidem Tartrate13 claims
QUALITY · MIPS · 2024
Final MIPS score
75.5
Quality
60.6
Cost
73.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.02%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.